SEEM!!!!  No ARE!!!!  The jury is out, because they, meaning stem cell 
researchers, have yet to produce results in humans.  I am of the opinion that 
we should fund what is producing results, gene therapy.  It has nothing to do 
with the morality of either process, it is purely results.  I want to see my 
buddies from the Army walk and talk again, and not have to ride around like 
Stephen Hawkings because of ALS.

All of the academic research I have seen towards a Parkinsons, MD or ALS cure 
is with stem cells.  That is fine with me as long as they do not destroy a 
human embryo to produce them.  Hell, I'll submit to lyposuction so stem cells 
can be harvested from my fat ass and belly if it will help.  

But the commercial research seems to be concentrating on, or at least producing 
results with, gene therapy research?  Why is this, could that be where viable 
results are at this time?

Politicizing the debate about stem cells (and I only oppose the use of 
embryonic stem cells that result from destroying an embryo) only hurts the 
research in the short and long term.  Get the scientists out of politics and 
the politicians out of science, and I'll be more open to thier arguments.

>EXACTLY!
>
>The science is simple: stem cells SEEM to be our best direction for
>research into cures.  I don't think anybody is saying they ARE a cure,
>only that they're the best direction for research.  That's science.
>
>Politics is saying that the research can't progress because there's
>morality concerns.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~|
Introducing the Fusion Authority Quarterly Update. 80 pages of hard-hitting,
up-to-date ColdFusion information by your peers, delivered to your door four 
times a year.
http://www.fusionauthority.com/quarterly

Archive: 
http://www.houseoffusion.com/groups/CF-Community/message.cfm/messageid:218469
Subscription: http://www.houseoffusion.com/groups/CF-Community/subscribe.cfm
Unsubscribe: 
http://www.houseoffusion.com/cf_lists/unsubscribe.cfm?user=11502.10531.5

Reply via email to